Skip to main content

Publication, Part of

Cancer Services Profiles, 2024 annual update

Official statistics

Publication Date:
3 Dec 2024
Geographic Coverage:
England
Page contents

Summary

The interactive Cancer Services profile tool has been updated to include the latest financial year of data that are available, collated by the National Disease Registration Service (NDRS). For most indicators, for example on screening, diagnostics and urgent suspected cancer referrals, the latest data is now available for the financial year 2023 to 2024. For the cancer incidence indicator, the tool has been updated to include the 2022 to 2023 data.

Background

The profiles have been designed to support commissioners and health professionals to assess the impact of cancer on their local population and make decisions about services.

These profiles present data by general practitioner (GP) practice, sub-Integrated Care Board (sub-ICB), Integrated Care Board (ICB) and at a national level on:

  • Cancer incidence and screening
  • Urgent suspected cancer (USC) referrals
  • Diagnostic services
  • Emergency presentations and admissions

Data are shown for the 6,253 GP practices that were active in the 2023 to 2024 financial year with a list size of 750 or more patients. It was assumed a practice was ‘active’ if there is  a record for it in the Quality and Outcomes Framework (QOF) 2023-24 and/or it both is included in the April 2024 Patients Registered at a GP Practice publication and has valid  GP patient survey data for 2024.

Acknowledgements

This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data is collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS England.

Key Facts

The latest national updates show that:

  • the number of new malignant cancer cases was updated for the financial year 2022 to 2023, reporting 341,857 new cases (excluding non-melanoma skin cancer), which is 548 cases per 100,000 population.
  • for the financial year 2023 to 2024, the proportion of eligible people who had a screening test result recorded within the relevant screening interval (screening coverage) was 69.9% for breast screening; 67.5% of those aged 25 to 49 and 74.9% of those aged 50 to 64 for cervical screening; and 71.8% of 60 to 74 years olds for bowel cancer screening.
  • for diagnostic investigations, per 100,000 population, there were 1,754 lower GI endoscopy procedures and 1,310 upper GI endoscopy procedures performed in the financial year 2023 to 2024.
  • the rate of individuals diagnosed with cancer through an emergency route was 89 per 100,000 population in the financial year 2023 to 2024.
  • there were 4,770 urgent suspected cancer (USC) referrals per 100,000 population in the financial year 2023 to 2024.

Last edited: 3 December 2024 9:31 am